CIM
AMED

Contravisory Investment Management’s Amedisys AMED Stock Holding History

Contravisory Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,706
Closed -$249K – 349
2024
Q1 		$249K Sell
2,706
-3
-0.1% -$281 0.06% 192
2023
Q4 		$258K Buy
+2,709
New +$253K 0.06% 182
2021
Q2 		– Sell
-834
Closed -$221K – 266
2021
Q1 		$221K Hold
834
– – 0.07% 162
2020
Q4 		$245K Sell
834
-38
-4% -$9.74K 0.08% 141
2020
Q3 		$206K Hold
872
– – 0.07% 148
2020
Q2 		$156K Buy
+872
New +$163K 0.06% 166

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Contravisory Investment Management's AMED Position: Q2 2024 in Review

Contravisory Investment Management sold out of Amedisys (AMED) in Q2 2024, closing a stake of 2,706 shares — an estimated $249K sold.

Contravisory Investment Management first reported a position in AMED in Q2 2020 and held it in 6 quarters. The position peaked at $258K in Q4 2023. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2024.

  • Contravisory Investment Management reported no remaining Amedisys position as of Q2 2024 after selling out during the quarter.
  • Contravisory Investment Management sold 2,706 Amedisys shares in Q2 2024, an estimated $249K.
  • Contravisory Investment Management first reported a position in Amedisys in Q2 2020 and held it in 6 quarters.
  • Contravisory Investment Management's Amedisys position peaked at $258K in Q4 2023.
  • 288 funds tracked by Wall St. Rank held Amedisys as of Q2 2024.

Based on Contravisory Investment Management's 13F filing for Q2 2024, filed 10 Jul 2024.